Cargando…

Human Vaccines & Immunotherapeutics: News

Measles vaccination: Targeted and non-targeted benefits CDC reports: 2-dose regimen of chickenpox vaccine is a success Positive preliminary results from the CAPiTA study Seasonal flu vaccine associate with reduced stroke risk HPV vaccine shown to halve cervical abnormalities Global prize for mobile...

Descripción completa

Detalles Bibliográficos
Autor principal: Riedmann, Eva M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896530/
http://dx.doi.org/10.4161/hv.29050
_version_ 1782436029688446976
author Riedmann, Eva M
author_facet Riedmann, Eva M
author_sort Riedmann, Eva M
collection PubMed
description Measles vaccination: Targeted and non-targeted benefits CDC reports: 2-dose regimen of chickenpox vaccine is a success Positive preliminary results from the CAPiTA study Seasonal flu vaccine associate with reduced stroke risk HPV vaccine shown to halve cervical abnormalities Global prize for mobile mast vaccine storage project Developmental pathway of potent HIV-neutralizing antibodies Burkholderia vaccine: US Dep of Defense collaborates with Bavarian Nordic
format Online
Article
Text
id pubmed-4896530
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-48965302016-06-24 Human Vaccines & Immunotherapeutics: News Riedmann, Eva M Hum Vaccin Immunother News, Policy & Profiles Measles vaccination: Targeted and non-targeted benefits CDC reports: 2-dose regimen of chickenpox vaccine is a success Positive preliminary results from the CAPiTA study Seasonal flu vaccine associate with reduced stroke risk HPV vaccine shown to halve cervical abnormalities Global prize for mobile mast vaccine storage project Developmental pathway of potent HIV-neutralizing antibodies Burkholderia vaccine: US Dep of Defense collaborates with Bavarian Nordic Taylor & Francis 2014-04-29 /pmc/articles/PMC4896530/ http://dx.doi.org/10.4161/hv.29050 Text en Copyright © 2014 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle News, Policy & Profiles
Riedmann, Eva M
Human Vaccines & Immunotherapeutics: News
title Human Vaccines & Immunotherapeutics: News
title_full Human Vaccines & Immunotherapeutics: News
title_fullStr Human Vaccines & Immunotherapeutics: News
title_full_unstemmed Human Vaccines & Immunotherapeutics: News
title_short Human Vaccines & Immunotherapeutics: News
title_sort human vaccines & immunotherapeutics: news
topic News, Policy & Profiles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896530/
http://dx.doi.org/10.4161/hv.29050
work_keys_str_mv AT riedmannevam humanvaccinesimmunotherapeuticsnews